- Home
- SNTI vs MOGU Comparison
SNTI vs MOGU Comparison
Compare SNTI & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- MOGU
- Stock Information
- Founded
- SNTI 2016
- MOGU 2011
- Country
- SNTI United States
- MOGU China
- Employees
- SNTI N/A
- MOGU N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- MOGU Business Services
- Sector
- SNTI Health Care
- MOGU Consumer Discretionary
- Exchange
- SNTI Nasdaq
- MOGU Nasdaq
- Market Cap
- SNTI 39.6M
- MOGU 19.8M
- IPO Year
- SNTI N/A
- MOGU 2018
- Fundamental
- Price
- SNTI $1.39
- MOGU $4.48
- Analyst Decision
- SNTI Strong Buy
- MOGU
- Analyst Count
- SNTI 2
- MOGU 0
- Target Price
- SNTI $8.50
- MOGU N/A
- AVG Volume (30 Days)
- SNTI 121.1K
- MOGU 3.7M
- Earning Date
- SNTI 11-13-2025
- MOGU 07-21-2025
- Dividend Yield
- SNTI N/A
- MOGU N/A
- EPS Growth
- SNTI N/A
- MOGU N/A
- EPS
- SNTI N/A
- MOGU N/A
- Revenue
- SNTI N/A
- MOGU $19,462,964.00
- Revenue This Year
- SNTI N/A
- MOGU N/A
- Revenue Next Year
- SNTI $150.00
- MOGU N/A
- P/E Ratio
- SNTI N/A
- MOGU N/A
- Revenue Growth
- SNTI N/A
- MOGU N/A
- 52 Week Low
- SNTI $1.26
- MOGU $1.83
- 52 Week High
- SNTI $16.94
- MOGU $8.10
- Technical
- Relative Strength Index (RSI)
- SNTI 39.50
- MOGU 69.30
- Support Level
- SNTI $1.33
- MOGU $4.10
- Resistance Level
- SNTI $1.42
- MOGU $5.50
- Average True Range (ATR)
- SNTI 0.07
- MOGU 0.60
- MACD
- SNTI 0.02
- MOGU 0.21
- Stochastic Oscillator
- SNTI 44.83
- MOGU 39.53
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.